Back to List View Graph View

Alzheimer's disease

Alzheimer's disease is a progressive neurodegenerative disorder and the most common cause of dementia in older adults.

Where the papers sit

25 papers from the last 6 months study alzheimer's disease directly · updated from PubMed 16 Nov 2026

  • Amyloid Biology and Therapeutics

    Amyloid pathology is being approached through combined diagnosis, immune reprogramming and multitarget neuroprotection. Microglial phagocytosis, lysosomal function and ISR suppression recur as therapeutic mechanisms. Nanocomposites, extracellular vesicles, cholinesterase inhibitors and small-molecule theranostics remain largely preclinical. Protein characterization and biomarker validation are central to moving these strategies toward translational testing.

    11 papers · 44%

  • Dementia Risk and Biomarkers

    Dementia research is moving toward earlier risk stratification through metabolic, genetic and disease-specific biomarkers. Insulin sensitivity, type 2 diabetes and antidiabetic medications are being examined as modifiable risk factors, although observational findings do not establish consistent protection. Clinical Dementia Rating and Alzheimer’s and Lewy body disease biomarkers help separate trajectories. Stimulation protocols and automated bio-electrical signal analysis extend this work toward individualized diagnosis and intervention.

    7 papers · 28%

  • Molecular Profiling of Dementia

    Sequencing and integrated omics are being used to connect disease heterogeneity with molecular and treatment-response signatures. RNA sequencing, metabolomics and 16S rRNA profiles support biomarker discovery, while localized feature selection addresses variation between individuals. Celastrol provides a pharmacological test case rather than a common treatment direction. The field remains exploratory, with validation and causal interpretation still open.

    3 papers · 12%

  • Others — Dementia Care and Outcomes

    Clinical management is being examined through medication exposure, healthcare utilization and outcomes after major events. Anti-herpetic drugs are linked to later Alzheimer’s treatment, while English cohort data describe disease burden and care pathways. Hip fracture studies focus on functional status, readmission, length of stay and mortality rather than disease mechanisms. A traditional formulation study adds preclinical neurobehavioral findings, leaving the cluster without a unified clinical direction.

    4 papers · 16%

NEW DIRECTION

Alzheimer’s disease biomarkers become prognostic markers within very late-onset schizophrenia-like psychosis

The very late-onset schizophrenia-like psychosis cohort studied AD and Lewy body disease biomarker status as determinants of progression in a psychiatric syndrome, rather than treating AD solely as the disease being diagnosed, modeled, or treated. Biomarker-positive participants showed more frequent dementia progression than biomarker-negative participants, and five of eight participants with AD biomarker positivity progressed to AD dementia. This recasts AD-related pathology as a latent neurodegenerative substrate that helps explain the course of another clinical disorder, creating a role not otherwise represented in the set 42575875Aug.

Papers

The 25 papers from the last 6 months that study alzheimer's disease directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Amyloid Biology and Therapeutics (11)
  1. MXene-Protein Corona Interfaces for Molecular Profiling of Alzheimer's Disease. ACS applied bio materials · 29 Oct 2026 PMID 42952081
  2. Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation. Biochemical and biophysical research communications · 11 Sept 2026 PMID 42727480
  3. Dioxaborinine-styrylquinoline hybrids as multitarget small-molecule theranostic compounds against Alzheimer's disease. Bioorganic chemistry · 10 Sept 2026 PMID 42721523
  4. Human amniotic mesenchymal stromal cell-derived extracellular vesicles reprogram microglia and prevent neurodegeneration in experimental models of Alzheimer's disease. Translational neurodegeneration · 9 Sept 2026 PMID 42711740
  5. Transcriptomic Signatures of Microglial Phagocytosis Reveal Diagnostic Markers and Immune Landscape in Alzheimer's Disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 28 Aug 2026 PMID 42663999
  6. Kaempferol-Conjugated Manganese Oxide Nanocomposites Mitigate Aluminium Chloride-Induced Neurobehavioral Impairments in a Rat Model of Alzheimer's disease. Journal of molecular neuroscience : MN · 4 Aug 2026 PMID 42550339
  7. New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 31 Jul 2026 PMID 42535978
  8. Accelerated Biological Aging, Neurodegenerative Disease, and Mortality in Cardiovascular Disease Patients: Mediation and Modification Analysis. CNS neuroscience & therapeutics · 29 Jul 2026 PMID 42524837
  9. Eugenol-derived carbamates as sub-nanomolar dual cholinesterase inhibitors with neuroprotective activity against Alzheimer's disease: Structure-activity relationships and molecular dynamics insights. Bioorganic chemistry · 13 Jul 2026 PMID 42442298
  10. Ribavirin mitigates Alzheimer's disease model phenotypes by enhancing lysosomal function and suppressing ISR. Bioorganic chemistry · 30 Jun 2026 PMID 42379016
  11. An LC-MS-guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease. Analytica chimica acta · 30 May 2026 PMID 42218000
Dementia Risk and Biomarkers (7)
  1. Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial. Trials · 9 Oct 2026 PMID 42855713
  2. Elucidating shared genetic signals between type 2 diabetes and three neurodegenerative dementia phenotypes. HGG advances · 2 Sept 2026 PMID 42681870
  3. Dementias in Older Women With Early-Stage HER2-Negative Breast Cancer Treated With Anthracycline Plus Taxane Versus Taxane-Based Chemotherapy Regimens. Pharmacoepidemiology and drug safety · 29 Aug 2026 PMID 42665946
  4. Antidiabetic medications and risk of cognitive disorders in type 2 diabetes: A retrospective cohort study. PloS one · 24 Aug 2026 PMID 42636218
  5. Progression to Dementia in Very Late-Onset Schizophrenia-Like Psychosis Stratified by Alzheimer's Disease and Lewy Body Disease Biomarkers: A Retrospective Cohort Study. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 10 Aug 2026 PMID 42575875
  6. Associations of Insulin Sensitivity with Risk of All-Cause and Cause-Specific Dementia: A Prospective Cohort Study. Molecular neurobiology · 18 Jul 2026 PMID 42470526
  7. CausalTCC: causal temporal contrastive learning for automated Alzheimer's disease biomarker discovery with bio-electrical signals. Journal of neural engineering · 2 Jul 2026 PMID 42392133
Molecular Profiling of Dementia (3)
  1. Uncovering heterogeneous effects via localized feature selection. Proceedings of the National Academy of Sciences of the United States of America · 15 Sept 2026 PMID 42743276
  2. EPIC4ND-European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases. European journal of epidemiology · 22 Jul 2026 PMID 42484778
  3. Integrating transcriptome, metabolome and 16S rRNA sequencing to reveal the effect of celastrol on Alzheimer's disease in rats. Scientific reports · 20 Jul 2026 PMID 42477465
Others — Dementia Care and Outcomes (4)
  1. Association between Alzheimer's disease and related dementias and postoperative outcomes after geriatric hip fracture surgery. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 11 Nov 2026 PMID 43013143
  2. Characterising patients with Alzheimer's disease in England: a cohort study using data from Clinical Practice Research Datalink linked to Hospital Episode Statistics. BMJ open · 28 Aug 2026 PMID 42665355
  3. Majoon-e-Boolis as a neurotherapeutic agent: cognitive and neuronal restoration in alzheimer's disease model. Metabolic brain disease · 12 Aug 2026 PMID 42584743
  4. Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort study. BMJ open · 15 Jun 2026 PMID 42297456

By study type

Clinical trials (1)
  1. Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial. Trials · 9 Oct 2026 PMID 42855713
Observational studies and case reports (7)
  1. Association between Alzheimer's disease and related dementias and postoperative outcomes after geriatric hip fracture surgery. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 11 Nov 2026 PMID 43013143
  2. Dementias in Older Women With Early-Stage HER2-Negative Breast Cancer Treated With Anthracycline Plus Taxane Versus Taxane-Based Chemotherapy Regimens. Pharmacoepidemiology and drug safety · 29 Aug 2026 PMID 42665946
  3. Characterising patients with Alzheimer's disease in England: a cohort study using data from Clinical Practice Research Datalink linked to Hospital Episode Statistics. BMJ open · 28 Aug 2026 PMID 42665355
  4. Antidiabetic medications and risk of cognitive disorders in type 2 diabetes: A retrospective cohort study. PloS one · 24 Aug 2026 PMID 42636218
  5. Progression to Dementia in Very Late-Onset Schizophrenia-Like Psychosis Stratified by Alzheimer's Disease and Lewy Body Disease Biomarkers: A Retrospective Cohort Study. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 10 Aug 2026 PMID 42575875
  6. Associations of Insulin Sensitivity with Risk of All-Cause and Cause-Specific Dementia: A Prospective Cohort Study. Molecular neurobiology · 18 Jul 2026 PMID 42470526
  7. Association between the use of anti-herpetic drugs and subsequent initiation of Alzheimer's disease drug treatment: Dutch population-based inception cohort study. BMJ open · 15 Jun 2026 PMID 42297456
Human data, design not indexed (7)
  1. MXene-Protein Corona Interfaces for Molecular Profiling of Alzheimer's Disease. ACS applied bio materials · 29 Oct 2026 PMID 42952081
  2. Uncovering heterogeneous effects via localized feature selection. Proceedings of the National Academy of Sciences of the United States of America · 15 Sept 2026 PMID 42743276
  3. Transcriptomic Signatures of Microglial Phagocytosis Reveal Diagnostic Markers and Immune Landscape in Alzheimer's Disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 28 Aug 2026 PMID 42663999
  4. New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 31 Jul 2026 PMID 42535978
  5. Accelerated Biological Aging, Neurodegenerative Disease, and Mortality in Cardiovascular Disease Patients: Mediation and Modification Analysis. CNS neuroscience & therapeutics · 29 Jul 2026 PMID 42524837
  6. CausalTCC: causal temporal contrastive learning for automated Alzheimer's disease biomarker discovery with bio-electrical signals. Journal of neural engineering · 2 Jul 2026 PMID 42392133
  7. An LC-MS-guided AI enabled serum molecule-interpretable SERS platform for exploratory metabolomic analysis in Alzheimer's disease. Analytica chimica acta · 30 May 2026 PMID 42218000
Preclinical: animal, cell and lab studies (7)
  1. Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation. Biochemical and biophysical research communications · 11 Sept 2026 PMID 42727480
  2. Dioxaborinine-styrylquinoline hybrids as multitarget small-molecule theranostic compounds against Alzheimer's disease. Bioorganic chemistry · 10 Sept 2026 PMID 42721523
  3. Human amniotic mesenchymal stromal cell-derived extracellular vesicles reprogram microglia and prevent neurodegeneration in experimental models of Alzheimer's disease. Translational neurodegeneration · 9 Sept 2026 PMID 42711740
  4. Majoon-e-Boolis as a neurotherapeutic agent: cognitive and neuronal restoration in alzheimer's disease model. Metabolic brain disease · 12 Aug 2026 PMID 42584743
  5. Kaempferol-Conjugated Manganese Oxide Nanocomposites Mitigate Aluminium Chloride-Induced Neurobehavioral Impairments in a Rat Model of Alzheimer's disease. Journal of molecular neuroscience : MN · 4 Aug 2026 PMID 42550339
  6. Eugenol-derived carbamates as sub-nanomolar dual cholinesterase inhibitors with neuroprotective activity against Alzheimer's disease: Structure-activity relationships and molecular dynamics insights. Bioorganic chemistry · 13 Jul 2026 PMID 42442298
  7. Ribavirin mitigates Alzheimer's disease model phenotypes by enhancing lysosomal function and suppressing ISR. Bioorganic chemistry · 30 Jun 2026 PMID 42379016
Unclassified: not yet indexed with MeSH (3)
  1. Elucidating shared genetic signals between type 2 diabetes and three neurodegenerative dementia phenotypes. HGG advances · 2 Sept 2026 PMID 42681870
  2. EPIC4ND-European Prospective Investigation into Cancer and Nutrition follow-up for neurodegenerative diseases. European journal of epidemiology · 22 Jul 2026 PMID 42484778
  3. Integrating transcriptome, metabolome and 16S rRNA sequencing to reveal the effect of celastrol on Alzheimer's disease in rats. Scientific reports · 20 Jul 2026 PMID 42477465